EA202092539A1 - NLRP3 MODULATORS - Google Patents
NLRP3 MODULATORSInfo
- Publication number
- EA202092539A1 EA202092539A1 EA202092539A EA202092539A EA202092539A1 EA 202092539 A1 EA202092539 A1 EA 202092539A1 EA 202092539 A EA202092539 A EA 202092539A EA 202092539 A EA202092539 A EA 202092539A EA 202092539 A1 EA202092539 A1 EA 202092539A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- nlrp3 modulators
- nlrp3
- modulators
- compounds
- medicaments
- Prior art date
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Настоящее изобретение обеспечивает соединения формулы (I)где все переменные являются такими, как определено в настоящем документе. Эти соединения являются модуляторами NLRP3, которые можно применять в качестве лекарственных средств для лечения пролиферативных нарушений, таких как рак, у субъекта (например, человека).The present invention provides compounds of formula (I) wherein all variables are as defined herein. These compounds are NLRP3 modulators that can be used as medicaments for the treatment of proliferative disorders, such as cancer, in a subject (eg, a human).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962825044P | 2019-03-28 | 2019-03-28 | |
PCT/US2019/028823 WO2019209896A1 (en) | 2018-04-25 | 2019-04-24 | Nlrp3 modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202092539A1 true EA202092539A1 (en) | 2021-02-16 |
Family
ID=74855483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202092539A EA202092539A1 (en) | 2019-03-28 | 2019-04-24 | NLRP3 MODULATORS |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA202092539A1 (en) |
-
2019
- 2019-04-24 EA EA202092539A patent/EA202092539A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020011234A (en) | Nlrp3 modulators. | |
EA202091491A1 (en) | NEW BENZYLAMINE SUBSTITUTED PYRIDOPYRIMIDINONES AND DERIVATIVES AS SOS1 INHIBITORS | |
NZ761519A (en) | Nlrp3 modulators | |
WO2018022668A3 (en) | Neuromodulating compositions and related therapeutic methods for the treatment of cancer | |
PH12019501097A1 (en) | Magl inhibitors | |
NZ750174A (en) | Somatostatin modulators and uses thereof | |
PH12019501102A1 (en) | Magl inhibitors | |
PH12020551934A1 (en) | Magl inhibitors | |
PH12019502646A1 (en) | Pyrazole magl inhibitors | |
PH12019502363A1 (en) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds | |
EA201990400A1 (en) | COMPOUNDS AND COMPOSITIONS AND THEIR APPLICATION | |
TR201900148T4 (en) | 2,4 diamino-quinoline substituted as novel agents against cancer. | |
AU2016380190A8 (en) | Deuterated compounds for treating cancer and related diseases and conditions, and compositions and methods thereof | |
PH12019502693A1 (en) | Heteroaromatic compounds as vanin inhibitors | |
PH12021551280A1 (en) | Heteroaromatic compounds as vanin inhibitors | |
MX2021006489A (en) | Heteroaromatic compounds as vanin inhibitors. | |
PH12021550269A1 (en) | Heteroaromatic compounds as vanin inhibitors | |
CL2019002583A1 (en) | Dual inhibitors of magl and faah. | |
MX2021006490A (en) | Heteroaromatic compounds as vanin inhibitors. | |
EA202092539A1 (en) | NLRP3 MODULATORS | |
EA202090283A1 (en) | NLRP3 MODULATORS |